The results indicated that higher levels of MRPL48 mRNA tended to be expressed in tissues obtained from HCC patients with advanced cancer stages (p < 0.01), and the highest mRNA levels of MRPL48 were predominantly found in patients at stages T2 and T3 (Fig. 3A). The gene discussed is MRPL48; the disease is hepatocellular carcinoma.